An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion.

Aptamers selected against various kinds of targets have shown remarkable specificity and affinity, similar to those displayed by antibodies to their antigens. To employ aptamers as genotyping reagents for the identification of pathogens and their strains, in vitro selections were carried out to find aptamers that specifically bind and distinguish the closely related human influenza A virus subtype H3N2. The selected aptamer, P30-10-16, binds specifically to the haemagglutinin (HA) region of the target strain A/Panama/2007/1999(H3N2) and failed to recognize other human influenza viruses, including another strain with the same subtype, H3N2. The aptamer displayed over 15-fold-higher affinity to the HA compared with the monoclonal antibody, and efficiently inhibited HA-mediated membrane fusion. These studies delineate the application of aptamers in the genotyping of viruses.

[1]  Hiroshi Mizuno,et al.  Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand , 2005, Nature.

[2]  Construction of a thermotaxis chamber providing spatial or temporal thermal gradients monitored by an infrared video camera system. , 1992, Analytical biochemistry.

[3]  Hidekazu Nishimura,et al.  Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus , 2004, Nature.

[4]  A. Pardi,et al.  High-resolution molecular discrimination by RNA. , 1994, Science.

[5]  Petra Burgstaller,et al.  Aptamers and aptazymes: accelerating small molecule drug discovery. , 2002, Current opinion in drug discovery & development.

[6]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[7]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[8]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[9]  Penmetcha K. R. Kumar,et al.  Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. , 2005, Analytical biochemistry.

[10]  H. U. Göringer,et al.  In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. , 2003, International journal for parasitology.

[11]  Satoshi Nishikawa,et al.  Structural basis of the highly efficient trapping of the HIV Tat protein by an RNA aptamer. , 2003, Structure.

[12]  D. Hoekstra,et al.  Fluorescence method for measuring the kinetics of fusion between biological membranes. , 1984, Biochemistry.

[13]  D. P. Sarkar,et al.  Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Knight,et al.  BayesFold: Rational 2° folds that combine thermodynamic, covariation, and chemical data for aligned RNA sequences , 2004 .

[15]  Digital fluorescence imaging of fusion of influenza virus with erythrocytes , 1989, FEBS letters.

[16]  S. Jeon,et al.  A DNA Aptamer Prevents Influenza Infection by Blocking the Receptor Binding Region of the Viral Hemagglutinin* , 2004, Journal of Biological Chemistry.

[17]  K. Machida,et al.  Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. , 1997, Virology.

[18]  A D Ellington,et al.  Aptamers as therapeutic and diagnostic reagents: problems and prospects. , 1997, Current opinion in chemical biology.

[19]  V. Remcho,et al.  Aptamers as analytical reagents , 2002, Electrophoresis.